SCN1A and Dravet syndrome: AAV-Navβ1, which drives β1 expression in central excitatory and inhibitory neurons, was previously developed as a potential treatment for SCN1A-linked DS, based on our work showing that β1 subunits function as plasma membrane chaperones and channel modulators of VGSC α subunits (25, 39).